Preprint Review Version 1 This version is not peer-reviewed

Individualized Management of Postoperative Radiotherapy for Patients with Diffuse Low-Grade Gliomas

Version 1 : Received: 13 August 2024 / Approved: 14 August 2024 / Online: 14 August 2024 (08:20:44 CEST)

How to cite: Zhang, X.; Wu, W.; Wang, Y.; Lian, X.; Ma, W. Individualized Management of Postoperative Radiotherapy for Patients with Diffuse Low-Grade Gliomas. Preprints 2024, 2024081011. https://doi.org/10.20944/preprints202408.1011.v1 Zhang, X.; Wu, W.; Wang, Y.; Lian, X.; Ma, W. Individualized Management of Postoperative Radiotherapy for Patients with Diffuse Low-Grade Gliomas. Preprints 2024, 2024081011. https://doi.org/10.20944/preprints202408.1011.v1

Abstract

This review explores the nuanced decision-making surrounding postoperative radiotherapy for diffuse low-grade glioma (DLGG) patients, emphasizing the need for personalized treatment to balance the benefits of tumor control with the risks of long-term side effects. Radiotherapy is a cornerstone of DLGG treatment, offering significant improvements in progression-free survival, but its potential for cognitive decline and vascular lesions necessitates careful consideration of individual patient factors. The review delves into the complexities of radiotherapy timing, revealing that while early radiotherapy enhances progression-free survival, it does not significantly impact overall survival and may lead to earlier onset of cognitive decline. Conversely, delayed radiotherapy may mitigate cognitive decline but may result in shorter progression-free survival and the onset of neurological symptoms. The review advocates for a patient-centered approach, emphasizing the importance of weighing individual risks and benefits, and highlights the potential of artificial intelligence in predicting cognitive decline and the need to revisit previous research findings in light of the 2021 WHO (World Health Organization) classification update, underscoring the evolving nature of DLGG treatment and the ongoing quest for optimal therapeutic strategies.

Keywords

Diffuse Low-Grade Glioma; Postoperative Radiotherapy; Individualized Treatment; Timing of Radiotherapy; Cognitive Decline

Subject

Medicine and Pharmacology, Clinical Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.